$13.97 -0.01 (-0.07%) Cellular Biomedicine Group Inc - NASDAQ

Aug. 31, 2016 | 04:00 PM
Last Trade: 13.97
Trade Time: Aug 31 04:00 PM Eastern Daylight Time
Change: -0.01 (-0.07%)
Prev Close: 13.98
Open: 13.93
Bid: 13.80
Ask: 13.97
  1. No results found.
  1. Cellular Biomedicine Group Names Tony Liu as CEO

    Benzinga | Jan. 28, 2016 | 06:07AM EST
  2. Cellular Biomedicine Group Announces CEO Cap To Be Replaced By Liu

    Benzinga | Jan. 11, 2016 | 09:03AM EST
  3. Cellular Biomedicine Group Announces Upcoming Presentation to Release 48-Week Data From Phase IIb Clinical Trial for Knee Osteoarthritis ReJoin® Stem Cell Therapy

    Benzinga | Dec. 22, 2015 | 09:00AM EST
  4. Cellular Biomedicine Group to Present Phase IIa Results from CAR-T CD20 Immuno-Oncology Clinical Development Program for Advanced Diffuse Large B Cell Lymphoma

    Benzinga | Oct. 23, 2015 | 08:16AM EST
  5. Cellular Biomedicine Group to Present CAR-T Phase I Clinical Trial Data for Non Small Cell Lung Cancer and Other Solid Tumors at 5th World Congress on Cancer Therapy

    Benzinga | Sep. 16, 2015 | 09:17AM EST
  6. Cellular Biomedicine Group to Release CAR-T for Non-Small Cell Lung Cancer Phase I Clinical Trial Data at 2015 European Cancer Congress

    Benzinga | Sep. 14, 2015 | 09:27AM EST
  7. Cellular Biomedicine Names Richard Wang as COO

    Benzinga | May. 27, 2015 | 08:06AM EST
  8. Benzinga's Volume Movers

    Benzinga | May. 22, 2015 | 10:26AM EST
  9. Cellular Biomedicine Group to Present Cancer CAR-T CD30 Therapy Clinical Development Program

    Benzinga | Apr. 27, 2015 | 09:30AM EST
  10. Cellular Biomedicine Group Announces New Facility in Beijing

    Benzinga | Apr. 22, 2015 | 09:39AM EST
  11. Morning Market Gainers

    Benzinga | Feb. 9, 2015 | 09:48AM EST
  12. Cellular Biomedicine Group Initiates Patient Recruitment for Cartilage Damage Stem Cell Therapy Clinical Research Study

    Benzinga | Jan. 6, 2015 | 08:02AM EST
  13. Events for the Week of Sept. 8-12

    Benzinga | Sep. 10, 2014 | 14:34PM EST
  14. Morning Market Movers

    Benzinga | Sep. 2, 2014 | 09:46AM EST
  15. Cellular Biomedicine Group Announces Acquisition of Immune Cell Therapy Technology And U.S. Patent; $3.28M In Cash + 753K In CBMG Stock & 75K In CBMG Restricted Units

    Benzinga | Aug. 4, 2014 | 09:19AM EST
Trading Center